Good Morning! THURSDAY, MARCH 26, 2015

Size: px
Start display at page:

Download "Good Morning! THURSDAY, MARCH 26, 2015"

Transcription

1 Good Morning! THURSDAY, MARCH 26, 2015

2 Prep A female newborn is noted to have a sacral subcutaneous lump with a fatty consistency and a slightly lateral deviation of the superior aspect of the inner gluteal fold. Her physical examination findings were otherwise normal, and there was no patellar hyper-reflexia. MRI of the thoracic and lumbar spine was obtained and showed a lipomeningomyelocele. It is unclear if the cord is tethered. The infant was referred to a multidisciplinary spina bifida clinic where renal ultrasonography was normal and urodynamic assessment showed no evidence of detrusor hyper-reflexia or bladder-sphincter dyssynergia. Of the following, the symptom or sign that you are most likely to look for during health supervision visits is A. Chronic progressive diarrhea B. Development of an ataxic gait C. Development of a sacral hemangioma D. Loss of patellar reflexes E. Urinary retention and leakage

3 Let s hear from our patient 2 1/2 yo female with diarrhea X 1 ½ weeks Loose (>10/day), frequency increasing? Blood-tinged today No fever, no emesis, no obvious abdominal pain Decreased PO; still has good UOP, although decreased from normal x2 days Has tried Pedialyte at home No other URI symptoms

4 Our patient BHx: 41 week vaginal delivery, prenatal care +, no complications, birthweight 7lb 12oz PMH: ALL diagnosed at 2 years Last Chemotherapy (VCR and Doxorubicin 1 week prior) PSH: PETs at 19 months, PAC placed at time of ALL diagnosis Meds: Biotene, Gabapentin, Bactrim for PCP prophylaxis, Zantac, Zofran Immunizations: UTD Allergies: NKDA FHx: paternal great-grandfather with skin cancer

5 Our patient (remember she s 2 ½) Vitals: T 98.1 P125 R24 BP 98/69 Gen: awake, alert, fussy but consolable Head: alopecia W11.7kg HEENT: conjunctivae clear but eyes appear sunken; OP clear but lips dry and mucous membranes tacky; unable to visualize TMs bilaterally due to cerumen CV/Resp: RRR, no murmur, cap refill <2sec, CTA B Abd/GU: BS x4, soft and nontender without guarding or rebound, no HSM, + diaper rash LAD: normal Skin: no rashes Neuro: grossly intact

6 What are you considering? Remember, she is immunocompromised! Medications Thyrotoxicosis

7 What do you want to do? (and what we did!) CBC CMP, Mg, Phos Stool Studies WBC Ova/Parasite Stool Culture C diff Rota/Adeno

8 Rehydration What % dehydrated is she?** Wt 11.7 kg She needs 700cc replaced Maintenance = 45cc/hr Bolus x1 700cc-220cc =480 cc to replace 240 over 8 hours = 30cc/hr + 45 cc/hr main 75cc/hr 240 over 16 hours = 15cc/hr + 45cc/hr main 60cc/hr

9 Results S/1B/49L/12M/1E/9ATL ANC 470 FOBT + Stool WBCs negative Ova/Parasite negative Adenovirus negative Rotavirus negative C. difficile toxin positive Ca 7.9 Mg 2.2 Phos /2.4/0.3/48/118/82

10 Clostridium difficile Anaerobic, spore-forming bacillus (spores are resistant to everything!) 30-70% of infants are asymptomatic carriers. Why? Disturbance of normal colonic flora allows C diff to grow spores produce toxins (A and B), causing mucosal damage Predisposing factors: Hospitalization, prolonged antibiotics, abdominal surgery, IBD, repeated enemas, immune deficiency Asymptomatic carriage mild diarrhea severe colitis toxic megacolon** Fever; crampy abdominal pain; foul-smelling, watery, often green stools** Blood or mucous present in those with colitis**

11 Clostridium difficile Stool studies: Toxin A and B by enzyme immunoassay** Toxin A- enterotoxin Toxin B- cytotoxin Studies show Toxin B is most important, those with strains lacking toxin A have disease similar to those with both toxins CBC: leukocytosis, possibly anemia Endoscopy:** Classic pseudomembrane is a white or yellow plaque along hyperemic and inflamed colonic mucosa Mucosa may be friable and erythematous without pseudomembrane

12 Clostridium difficile Contact precautions** Alcohol-based products do not kill Soap and water best for hand hygiene, bleach for cleaning surfaces Discontinue offending ABX if possible! (duh!) Flagyl 20mg/kg/day divided QID for days (max of 1g/day)** Relapse** 10-20% relapse in 4 weeks of stopping therapy due to: re-infection, persistent spores, chronic ABX, pre-disposing underlying disease First relapse: repeat Flagyl Second relapse: vancomycin 40mg/kg/day PO divided QID or days Chronic relapsing- PO vancomycin for 1-3 months + one off the following: cholestyramine, lactobacillus, GOLYTELY bowel irrigation, IVIG, saccharomyces boulardii

13 But wait Our patient developed abdominal pain with grossly bloody stools Hypotension Fever Now what are you concerned about, and what do you want to do?

14 New Results Blood Culture Gram Negative 0.5days Klebsiella pneumoniae Urine Culture No growth Abdominal CT Extensive submucosal and subserosal colonic pneumatosis (cecum, ascending colon, sigmoid, rectum) Extensive air expanding the submucosal space present in sigmoid and rectum wall with free air dissecting into retroperitoneal soft tissues in pelvis No free intra-abdominal air Residual colon with wall edema with mucosal hyperenhancement indicative of colitis

15 Neutropenic Enterocolitis Life-threatening, necrotizing enterocolitis Most common in those with hematologic malignancies who are neutropenic and have breakdown of gut mucosa secondary to cytotoxic chemo Typhlitis NE of ileocecal region Pathophysiology involves combination of mucosal injury by drugs, profound neutropenia, impaired host defense to invasion by microorganisms Microbial infection leads to necrosis of various layers of bowel wall Involved parts: Cecum most commonly involved Extends into ascending colon and terminal ileum

16 Typhlitis Micro seen: Pseudomonas aeruginosa Escherichia coli Klebsiella spp Viridans group strep Enterococci Bacteroides spp Clostridium spp Candida spp Risk factors: Initially seen in those receiving induction chemo for ALL Increased associated now in those with mucositis, HSCT, and chemo within past 2 weeks Frequency is increasing with use of cytotoxic drugs: Taxanes Cytarabine Idarubicin Vinorelbine 5-FU Cyclophosphamide Ifosfamide Cisplatin Carboplatin

17 Typhlitis Must consider in ANY severely neutropenic patient (ANC <500) who presents with fever and abdominal pain Often RLQ Rule out appendicitis!!, GVHD, colonic pseudoobstruction Fever typically presents during 3 rd week after chemo Distension, cramping, tenderness, NV, watery or bloody diarrhea, frank hematochezia Peritoneal signs and shock suggest perforation CT is preferred imaging (attempt po and iv contrast) Bowel wall thickening (100%) Mesenteric stranding, bowel dilatation, mucosal enhancement, pneumoatosis C diff toxin if not already done!

18 Typhlitis Bowel rest, NG suction, IVFs, Blood product support Antibiotics Active against: pseudomonas, E coli, other GNR, anaerobes Regimens 1. Piperacillin/tazobactam (Zosyn) 2. Cefepime or Ceftazidime + Flagyl 3. Imipenem or Meropenem (if allergic or know bug is resistant) Cover for C diff if it has not been excluded Antifungal? If fever present >72 hours after antibiotics started If no signs of severe disease, continue for 14 days following recovery from PO if no bacteremia and doing clinically well AF x 2 days and counts >500 (Augmentin or Cipro + Flagyl) Surgery?

19 Typhlitis May remain febrile until recovery from neutropenia, despite antibiotics G-CSF? Delay further chemo until full recovery Early recognition and progress in management have reduced mortality Initially 50% mortality No major studies demonstrating this Prone to develop again during subsequent treatments Finishing our patient

20 Noon conference: Dr Creel. Delivering Bad News, Room 3302 ACC Have a great day!

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System CLOSTRIDIUM DIFICILE Negin N Blattman Infectious Diseases Phoenix VA Healthcare System ANTIBIOTIC ASSOCIATED DIARRHEA 1978: C diff first identified 1989-1992: Four large outbreaks in the US caused by J

More information

... Inflammatory disorder of the colon that occurs as a complication of antibiotic treatment.

... Inflammatory disorder of the colon that occurs as a complication of antibiotic treatment. Definition Inflammatory disorder of the colon that occurs as a complication of antibiotic treatment. " Epidemiology Humans represent the main reservoir of Clostridium difficile, which is not part of the

More information

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual

More information

Clostridium Difficile Infection in Adults Treatment and Prevention

Clostridium Difficile Infection in Adults Treatment and Prevention Clostridium Difficile Infection in Adults Treatment and Prevention Definition: Clostridium Difficile colonizes the human intestinal tract after the normal gut flora has been altered by antibiotic therapy

More information

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Clostridium Difficile Associated Disease Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Introduction Which of the following is more common in community hospitals in the Southeast

More information

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated

More information

Neutropenic Fever. CID 2011; 52 (4):e56-e93

Neutropenic Fever.  CID 2011; 52 (4):e56-e93 Neutropenic Fever www.idsociety.org CID 2011; 52 (4):e56-e93 Definitions Fever: Single oral temperature of 101 F (38.3 C) Temperature 100.4 F (38.0 C) over 1 hour Neutropenia: ANC < 500 cells/mm 3 Expected

More information

Case Presentation: Mr. S

Case Presentation: Mr. S Case Presentation: Mr. S History Seen as inpatient in May, but has significant prior history and is a poor historian 53 y.o. Male no PMH, has been out of contact with medicine for years aside from hernia

More information

! MQ is a 44 year old woman that I first saw in Sept ! In MVA in Jan 2003 requiring spinal surgery

! MQ is a 44 year old woman that I first saw in Sept ! In MVA in Jan 2003 requiring spinal surgery Case MQ is a 44 year old woman that I first saw in Sept 2006 UPDATE ON CLOSTRIDIUM DIFFICILE DISEASE Richard A. Jacobs, M.D.,PhD In MVA in Jan 2003 requiring spinal surgery Subsequently developed fecal

More information

Clostridium difficile Infection: Diagnosis and Management

Clostridium difficile Infection: Diagnosis and Management Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,

More information

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Case 1 21 yr old HIV +ve, Cd4-100 HAART naïve Profuse diarrhoea for 3/52. Stool MC&S ve Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Repeat stool MC&S Stool

More information

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI) Clostridium Difficile: Updates on Diagnosis and Treatment Elizabeth Hudson, DO, MPH 9/25/18 Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics In

More information

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical

More information

3/22/2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease Objectives: Appendicitis. Lemone and Burke Chapter 26

3/22/2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease Objectives: Appendicitis. Lemone and Burke Chapter 26 Inflammatory Bowel Disease Lemone and Burke Chapter 26 Inflammatory Bowel Disease Objectives: Discuss etiology, patho and clinical manifestations of Appendicitis Peritonitis Ulcerative Colitis Crohn s

More information

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003 Surgical Management of IBD Val Jefford Grand Rounds October 14, 2003 Introduction Important Features Clinical Presentation Evaluation Medical Treatment Surgical Treatment Cases Overview Introduction Two

More information

more intense treatments are needed to get rid of the infection.

more intense treatments are needed to get rid of the infection. What Is Clostridium Difficile (C. Diff)? Clostridium difficile, or C. diff for short, is an infection from a bacterium that can grow in your intestines and cause bad GI symptoms. The main risk of getting

More information

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers Disclosures No conflict of interest to declare Acknowledgments Objectives and Agenda Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Guidelines

More information

Interactive Cases. Victor Tseng, MD

Interactive Cases. Victor Tseng, MD Interactive Cases Victor Tseng, MD WHO HAS A NEUTROPENIC FEVER? 61 M ANC 800 + T 38.9 being treated for stage IIIA CRC 22 F ANC 120 + T 37.0 getting consolidation for ALL 53 F ANC 580 (710 yesterday)

More information

Citywide Infectious Disease Conference. March 27 th, 2018

Citywide Infectious Disease Conference. March 27 th, 2018 Citywide Infectious Disease Conference March 27 th, 2018 Citywide Show and Tell Case 1 Summary 60 s year old Puerto Rican born man SCC of Esophagus, treated with radiation and chemotherapy and then esophageal

More information

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH Some history first Clostridium difficile, a spore-forming gram-positive (i.e., thick

More information

Clostridium difficile Essential information

Clostridium difficile Essential information Clostridium difficile Essential information Clostridium difficile Origins Clostridium difficile (C. diff) is a Gram positive, spore forming, anaerobic bacterium with a rod structure. It was first identified

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Alex Aspinall MD, PhD, FRCPC Clinical Assistant Professor, University of Calgary Division of Gastroenterology and Hepatology, South Health Campus www.seacourses.com 1 Learning Points

More information

GI Bacterial Infections (part-2)

GI Bacterial Infections (part-2) GI Bacterial Infections (part-2) Mohammed Abdulla Mehdi FIBMS (internal medicine), FIBMS (G&H) Clostridium difficile infection C. difficile is the most commonly diagnosed cause of antibioticassociated

More information

Septic Shock. Kathryn Sims, PGY I

Septic Shock. Kathryn Sims, PGY I Septic Shock Kathryn Sims, PGY I A 6 y.o. previously healthy boy presents to the ED with 7 days of fever accompanied by chills. Further history reveals the patient has also been experiencing dysuria for

More information

URINARY TRACT INFECTIONS

URINARY TRACT INFECTIONS URINARY TRACT INFECTIONS Learning Objectives Identify signs and symptoms that may indicate presence of UTI (both complicated and uncomplicated) List common causative organisms and risk factors for UTIs

More information

Case 1. Case Discussion. History. Present Illness. Impression. Physical Examination

Case 1. Case Discussion. History. Present Illness. Impression. Physical Examination Case 1 Case Discussion R1 林吉倡 2013 / 01 / 02 13-yo Male BW: 45 kg DAY1 16:35 pm C/C: Epigastric pain since this morning TPR: 36.5/94/18 BP:133/83 SpO2: 100% GCS: 15 Triage: 2 Present Illness Sudden-onset

More information

Clostridium difficile Infection (CDI) Management Guideline

Clostridium difficile Infection (CDI) Management Guideline Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for

More information

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment. C. DIFFICILE Case definition CONFIRMED CASE A patient is defined as a case if they are one year of age or older AND have one of the following requirements: A laboratory confirmation of a positive toxin

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013 Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013 Financial Disclosures No financial disclosures Objectives Review a case of recurrent Clostridium difficile infection

More information

INTRA-ABDOMINAL INFECTIONS

INTRA-ABDOMINAL INFECTIONS INTRA-ABDOMINAL INFECTIONS Learning Objectives: 1. Describe patient risk factors, signs and symptoms that may indicate an intra-abdominal infection 2. Identify tests and significant laboratory values used

More information

Incidence of and risk factors for communityassociated Clostridium difficile infection

Incidence of and risk factors for communityassociated Clostridium difficile infection University of Iowa Iowa Research Online Theses and Dissertations 2010 Incidence of and risk factors for communityassociated Clostridium difficile infection Jennifer Lee Kuntz University of Iowa Copyright

More information

General Data. 王 X 村 78 y/o 男性

General Data. 王 X 村 78 y/o 男性 General Data 王 X 村 78 y/o 男性 Chief Complaint Vomiting twice this early morning Fever up to 38.9ºC was noted Present Illness (1) Old CVA with left side weakness for more than 10 years and with bed ridden

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Inflammatory Bowel Disease When is diarrhea not just diarrhea? Inflammatory Bowel Disease When is diarrhea not just diarrhea? Jackie Kazik, MA, PA C CME Resources CAPA Annual Conference, 2011 Inflammatory Bowel Disease Objectives Discuss what is known about the pathophysiology

More information

Evaluating the CT Diagnosis of Clostridium difficile Colitis: Should CT Guide Therapy?

Evaluating the CT Diagnosis of Clostridium difficile Colitis: Should CT Guide Therapy? Iain D. C. Kirkpatrick 1 Howard M. Greenberg Received April 7, 2000; accepted after revision August 24, 2000. 1 Both authors: Department of Radiology, University of Manitoba, Health Sciences Centre, 820

More information

Acute Cholangitis. Kelsey Knotts PharmD Candidate Class of 2016

Acute Cholangitis. Kelsey Knotts PharmD Candidate Class of 2016 Acute Cholangitis Kelsey Knotts PharmD Candidate Class of 2016 Learning Objectives 1. Describe the mechanism of the development of acute cholangitis 2. Identify common causative organisms in acute cholangitis

More information

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection

More information

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic

More information

Management of the Hospitalized IBD Patient. Drew DuPont MD

Management of the Hospitalized IBD Patient. Drew DuPont MD Management of the Hospitalized IBD Patient Drew DuPont MD Ulcerative Colitis: Indications for Admission Severe ulcerative colitis Frequent loose bloody stools ( 6 per day) Severe cramps Systemic toxicity:

More information

Case in Point III. A Collection of Closed Claims Focusing on Diagnostic Errors

Case in Point III. A Collection of Closed Claims Focusing on Diagnostic Errors Case in Point III A Collection of Closed Claims Focusing on Diagnostic Errors Case in Point III A Collection of Closed Claims Focusing on Diagnostic Errors Case in Point III Contributors/Editors Beth Atwell

More information

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma

More information

MANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13

MANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13 MANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13 CASE THE PATIENT IS A 79 YEAR OLD MALE WITH 3 DAY HISTORY OF LOWER ABDOMINAL PAIN, NAUSEA WITHOUT VOMITING, CHILLS

More information

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile OBJECTIVES HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile Identify and describe the pathophysiology of C. diff. Identify and describe current therapies in treatment of C. diff Identify

More information

A Pharmacist Perspective

A Pharmacist Perspective Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Christopher Lau Kings County Hospital SUNY Downstate Medical Center February 24, 2011

Christopher Lau Kings County Hospital SUNY Downstate Medical Center February 24, 2011 Christopher Lau Kings County Hospital SUNY Downstate Medical Center February 24, 2011 37 year old male presented with 1 day history of abdominal pain Pain was diffuse but worst in the epigastric area No

More information

A Perf-ect Differential

A Perf-ect Differential A Perf-ect Differential Carolyn Marcus, MD Disclosure of Financial Relationships Husband works as in-house legal counsel at Sanofi Case Presentation 6 year old boy with a history of constipation presents

More information

11/21/2017 JUST THE FACTS!

11/21/2017 JUST THE FACTS! JUST THE FACTS! Katharine C Long, MD Establish differential diagnosis for the critically ill infant Create management approach for the critically ill infant Identify laboratory tests and interventions

More information

Abdominal Pain. Luke Donnelly, MD Emergency Medicine

Abdominal Pain. Luke Donnelly, MD Emergency Medicine Abdominal Pain Luke Donnelly, MD Emergency Medicine Objectives Approach to abdominal pain Evaluation Critical diagnoses and treatments Abdominal Pain Most Common ER Complaint Broad Differential Can often

More information

Diarrhoea on the AMU. Dr Chris Roseveare

Diarrhoea on the AMU. Dr Chris Roseveare Diarrhoea on the AMU Dr Chris Roseveare The Society for Acute Medicine, Spring Meeting, Radisson Blu Hotel, Dublin 3-4 May 2012 Acute diarrhoea in developed countries adult populations Mainly a primary

More information

SMT19969: A Selective Therapy for C. difficile Infection

SMT19969: A Selective Therapy for C. difficile Infection SMT19969: A Selective Therapy for C. difficile Infection One Bug, One Drug 25 th September 2012 SMT19969: A Selective Therapy for CDI SMT19969 is a novel antibiotic for the specific treatment of Clostridium

More information

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,

More information

FOODBORNE INFECTIONS. Caroline Charlier-Woerther March 2017

FOODBORNE INFECTIONS. Caroline Charlier-Woerther March 2017 FOODBORNE INFECTIONS Caroline Charlier-Woerther March 2017 LEARNING OBJECTIVES Know the pathogens involved in diarrheas Know the basics of management of diarrhea Know the main patterns of listeriosis and

More information

What s New for Clostridium difficile John Lynch MD MPH Harborview Medical Center University of Washington

What s New for Clostridium difficile John Lynch MD MPH Harborview Medical Center University of Washington What s New for Clostridium difficile 2013 John Lynch MD MPH Harborview Medical Center University of Washington Pathogenic Mechanisms of Diarrhea Toxins: Preformed: S aureus, C perfringens, B cereus Formed

More information

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile. Janel Liane Cala, RPh Medical Center Hospital

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile. Janel Liane Cala, RPh Medical Center Hospital Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review pathophysiology, risk factors, prevention, and treatment options of

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

Urinary Tract Infections in Hospitalized Patients

Urinary Tract Infections in Hospitalized Patients Urinary Tract Infections in Hospitalized Patients Puerto Rico Chapter Annual Meeting Daniel C. DeSimone, MD March 9, 2019 2017 MFMER slide-1 Disclosures for speaker: Date of presentation: 3/9/2019 No relevant

More information

GI Bacterial Infections (part-1)

GI Bacterial Infections (part-1) GI Bacterial Infections (part-1) Mohammed Abdulla Mehdi FIBMS (internal medicine), FIBMS (Gastroenterology & Hepatology) Acute diarrhea and vomiting Acute diarrhea, sometimes with vomiting, is the predominant

More information

Microbial Flora of Normal Human Body Dr. Kaya Süer. Near East University Medical Faculty Infectious Diseases and Clinical Microbiology

Microbial Flora of Normal Human Body Dr. Kaya Süer. Near East University Medical Faculty Infectious Diseases and Clinical Microbiology Microbial Flora of Normal Human Body Dr. Kaya Süer Near East University Medical Faculty Infectious Diseases and Clinical Microbiology Normal Microbial Flora Skin Conjunctivae Oral Cavity Upper respiratory

More information

1/21/2016. Overview. Significance

1/21/2016. Overview. Significance Asymptomatic Bacteriuria: Myths, Magic and Management Christopher Ohl MD Professor of Medicine, Section on Infectious Diseases Wake Forest School of Medicine, Winston Salem, NC Slide credits to Katie Wallace,

More information

Paediatric Directorate

Paediatric Directorate Paediatric Directorate Dehydration Guidelines Primary cause of dehydration diarrhoea +/- vomiting. Approximately 10%Children < 5yrs present with gastroenteritis each year Diagnosis History - sudden change

More information

Managing Clostridium Difficile: An Old Bug With

Managing Clostridium Difficile: An Old Bug With 932 The Red Section see related editorial on page x Managing Clostridium Difficile: An Old Bug With New Tricks Stephen M. Vindigni, MD, MPH 1,2 and Christina M. Surawicz, MD 1 Am J Gastroenterol (2018)

More information

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) What is Clostridium difficile? Clostridium difficile is a Gram-positive anaerobic spore forming bacillus. It is ubiquitous in nature and

More information

Lanny Hsieh, M.D. Infectious Diseases Hospitalist Program

Lanny Hsieh, M.D. Infectious Diseases Hospitalist Program Lanny Hsieh, M.D. Infectious Diseases Hospitalist Program Definition of Fever Arbitrary 38.0-38.4 (low grade may be significant in immunocompromised patients) > 38.5 (nurse will call you) Be aware of

More information

Updates to pharmacological management in the prevention of recurrent Clostridium difficile

Updates to pharmacological management in the prevention of recurrent Clostridium difficile Updates to pharmacological management in the prevention of recurrent Clostridium difficile Julia Shlensky, PharmD PGY2 Internal Medicine Resident September 12, 2017 2017 MFMER slide-1 Clinical Impact Increasing

More information

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click

More information

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD GOOD MORNING! Thursday, July 10 2014 Heidi Murphy, MD Leslie Carter-King, MD PREP QUESTION Almost all infants experience a transient increase in bilirubin concentrations known as physiologic jaundice during

More information

Right Iliac Fossa Pain

Right Iliac Fossa Pain Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Right Iliac Fossa Pain Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should

More information

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized

More information

PSEUDOMEMBRANOUS COLITIS: LOCAL EXPERIENCE WITH 3 CASES

PSEUDOMEMBRANOUS COLITIS: LOCAL EXPERIENCE WITH 3 CASES Med. J. Malaysia Vol. 41 No. 4 December 1986 PSEUDOMEMBRANOUS COLITIS: LOCAL EXPERIENCE WITH 3 CASES K. L. GOH S. C. PEH N. W. WONG SUMMARY Three cases of pseudomembranous colitis seen over the past one

More information

Clostridium Difficile colitismore

Clostridium Difficile colitismore Clostridium Difficile colitismore virulent than ever ECHO- February 18, 2016 Charles Krasner, M.D. UNR School of Medicine Sierra NV Veterans Affairs Hospital Growing problem of pseudomembranous colitis

More information

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Fever National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Case 1 4-month-old well-appearing girl admitted for croup and respiratory distress.

More information

Clostridium difficile infections: Drug treatment re-evaluated

Clostridium difficile infections: Drug treatment re-evaluated Clostridium difficile infections: Drug treatment re-evaluated Kimberly D. Leuthner, PharmD University Medical Center of Southern Nevada August 11, 2016 Random Fact: The human body has 10 13 human cells

More information

Modern approach to Clostridium Difficile Infection

Modern approach to Clostridium Difficile Infection Modern approach to Clostridium Difficile Infection Pseudomembranous Colitis: Principles for diagnosis and treatment Aggelos Stefos Internist, Infectious diseases Specialist Department of Medicine and Research

More information

Management of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery

Management of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery Management of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery Rahul Narang, MD Colon and Rectal Surgery Assistant Professor of Surgery No Disclosure Clostridium Difficile Colitis: Treatments,

More information

Neutropenic Fever 1 InpatientPediatric Treatment

Neutropenic Fever 1 InpatientPediatric Treatment Neutropenic Fever InpatientPediatric Treatment (Hematologic Cancers and Stem Cell Patients) te: This algorithm should not be used for patients receiving CAR cell therapy. Page of 8 Patient presents with

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Care Homes IPC Study Day Sue Barber Infection Prevention & Control Lead AV & Chiltern CCG s Clostridium difficile A spore forming Bacterium. Difficult to grow in the laboratory hence

More information

Bacterial Infections in Neutropenic Patients and HSCT Recipients. Outline. Course of BMT

Bacterial Infections in Neutropenic Patients and HSCT Recipients. Outline. Course of BMT Bacterial Infections in Neutropenic Patients and HSCT Recipients Kieren A. Marr MD Professor of Medicine and Oncology Director, Transplant and Oncology ID Johns Hopkins University School of Medicine Outline

More information

Christina Tennyson, M.D. Division of Gastroenterology

Christina Tennyson, M.D. Division of Gastroenterology Diarrhea Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University DIARRHEA Symptom: stool frequency, liquidity Sign: > 200-250 g/day Acute Chronic Time

More information

2/26/2009. Diarrhea. Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University

2/26/2009. Diarrhea. Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University Diarrhea Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University 1 Symptom: Sign: DIARRHEA stool frequency, liquidity > 200-250 g/day Acute Chronic Time

More information

ID Emergencies. BGSMC Internal Medicine Edwin Yu

ID Emergencies. BGSMC Internal Medicine Edwin Yu ID Emergencies BGSMC Internal Medicine Edwin Yu Learning Objectives Bacterial meningitis IDSA guidelines: Clin Infect Dis 2004; 39:1267-84 HSV encephalitis IDSA guidelines: Clin Infect Dis 2008; 47:303-27

More information

Treating and Preventing. C. difficile Infections A Review of the Research for Adults

Treating and Preventing. C. difficile Infections A Review of the Research for Adults Treating and Preventing C. difficile Infections A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional has said that

More information

Good Morning! March 23, 2015

Good Morning! March 23, 2015 Good Morning! March 23, 2015 Prep Question You are caring for an 8-year-old girl who was involved in a motor vehiclepedestrian crash. Despite maximal medical and surgical therapy, she developed intractable

More information

URINARY TRACT INFECTIONS 3 rd Y Med Students. Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan

URINARY TRACT INFECTIONS 3 rd Y Med Students. Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan URINARY TRACT INFECTIONS 3 rd Y Med Students Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan Urinary Tract Infections-1 Normal urine is sterile.. It contains fluids, salts, and waste products,

More information

Uroradiology Tutorial For Medical Students

Uroradiology Tutorial For Medical Students Uroradiology Tutorial For Medical Students Lesson 3: Cystography & Urethrography Part 1 American Urological Association Introduction Conventional radiography of the urinary tract includes several diagnostic

More information

2/3/2011. Adhesion of Bifidobacterium lactis HN019 to human intestinal

2/3/2011. Adhesion of Bifidobacterium lactis HN019 to human intestinal PROBIOTICS LEARNING THE WHY AND WHEN PROBIOTICS DEFINITION live micro-organisms organisms that are beneficial to the host organism WHO: Live organisms which, when administered in adequate amounts, confer

More information

MODULE VI. Diarrhea and Dehydration

MODULE VI. Diarrhea and Dehydration MODULE VI Diarrhea and Dehydration ACUTE DIARRHEA Increased number of bowel movements! Loose and watery stools Fluid and electrolyte loss ACUTE DIARRHEA TYPES Watery Bloody diarrhea (dysentery) DIARRHEA

More information

Fecal transplantation as a treatment option for recurrent Clostridium difficile infection

Fecal transplantation as a treatment option for recurrent Clostridium difficile infection Fecal transplantation as a treatment option for recurrent Clostridium difficile infection Josbert Keller Department of Gastroenterology Haga Teaching Hospital, The Hague Case: 81 yrs, CVA, recurrent UTI,

More information

2018 CNISP HAI Surveillance Case definitions

2018 CNISP HAI Surveillance Case definitions 2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the

More information

Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018

Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018 Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018 Disclosures None Objectives Highlight important changes in the management of Clostridium difficile

More information

Development of C sporins. Beta-lactam antibiotics - Cephalosporins. Second generation C sporins. Targets - PBP s

Development of C sporins. Beta-lactam antibiotics - Cephalosporins. Second generation C sporins. Targets - PBP s Beta-lactam antibiotics - Cephalosporins Development of C sporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability properties

More information

APPENDICITIS IN THE YOUNG CHILD. By Rebecca Lucas

APPENDICITIS IN THE YOUNG CHILD. By Rebecca Lucas 1 APPENDICITIS IN THE YOUNG CHILD By Rebecca Lucas 2 When time counts the most Patient Profile 3 The patient 3 years old 2 months girl Usually is vibrant, articulate, incorrigible enjoys telling me how

More information

Real Cases: Bad Outcomes

Real Cases: Bad Outcomes Real Cases: Bad Outcomes Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical

More information

Pembrozulimab Induced Collagenous Colitis. Mokshya Sharma 1, MD, Santhosh Ambika 2, MD University of Nevada, Reno SOM

Pembrozulimab Induced Collagenous Colitis. Mokshya Sharma 1, MD, Santhosh Ambika 2, MD University of Nevada, Reno SOM Pembrozulimab Induced Collagenous Colitis Mokshya Sharma 1, MD, Santhosh Ambika 2, MD University of Nevada, Reno SOM Background Immune modulating therapy that targets PD1 pathway such as pembrozulimab

More information

11 year-old female with altered mental status in the setting of diabetic ketoacidosis

11 year-old female with altered mental status in the setting of diabetic ketoacidosis 11 year-old female with altered mental status in the setting of diabetic ketoacidosis Katie O Sullivan, M.D. Fellow Adult/Pediatric Endocrinology University of Chicago Thursday, January 23 rd, 2014 Chief

More information

Chronic diarrhea. Dr.Nasser E.Daryani Professor of Tehran Medical University

Chronic diarrhea. Dr.Nasser E.Daryani Professor of Tehran Medical University 1 Chronic diarrhea Dr.Nasser E.Daryani Professor of Tehran Medical University Timing Acute diarrhea: 4 weeks Definitions Derived from Greek

More information

BC Cancer Protocol Summary for the Maintenance Therapy of Multiple Myeloma Using Bortezomib for Patients with the High-Risk Chromosome Abnormality

BC Cancer Protocol Summary for the Maintenance Therapy of Multiple Myeloma Using Bortezomib for Patients with the High-Risk Chromosome Abnormality BC Cancer Protocol Summary for the Maintenance Therapy of Multiple Myeloma Using Bortezomib for Patients with the High-Risk Chromosome Abnormality Protocol Code Tumour Group Contact Physician MYBORMTN

More information

Neutropenic Enterocolitis in Breast Cancer Patient after Taxane Containing

Neutropenic Enterocolitis in Breast Cancer Patient after Taxane Containing Neutropenic Enterocolitis in Breast Cancer Patient after Taxane Containing Chemotherapy Amaylia Oehadian, Trinugroho Heri Fadjari Division of Hematology and Medical Oncology, Department of Internal Medicine,

More information